MARKET

ELOX

ELOX

Eloxx Pharmaceut
NASDAQ
10.95
-0.61
-5.28%
Pre Market: 12.34 +1.39 +12.69% 07:52 07/08 EDT
OPEN
12.00
PREV CLOSE
11.56
HIGH
12.95
LOW
10.84
VOLUME
2
TURNOVER
2.94K
52 WEEK HIGH
17.50
52 WEEK LOW
0.0011
MARKET CAP
44.20M
P/E (TTM)
-12.7846
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELOX last week (0629-0703)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors
TipRanks · 07/01 16:33
Weekly Report: what happened at ELOX last week (0622-0626)?
Weekly Report · 06/29 10:14
Weekly Report: what happened at ELOX last week (0615-0619)?
Weekly Report · 06/22 10:22
Eloxx Pharmaceuticals initial beneficial ownership filing names Domicilium Real Estate Fund III LP as 10% owner
PUBT · 06/17 21:11
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 06/17 21:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 06/17 12:06
More
About ELOX
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Webull offers Eloxx Pharmaceuticals Inc stock information, including NASDAQ: ELOX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELOX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELOX stock methods without spending real money on the virtual paper trading platform.